Tissue plasminogen activator for treatment of fibrin in endophthalmitis

Canadian Journal of Ophthalmology

Volumn 36, Issue 5, 2001, Pages 269-271

  Damji, Karim F ^a   O'Connor, Michael D ^a   Hill, Vivian ^a  

^a UNIVERSITY OF OTTAWA EYE INSTITUTE   (Canada)

Author keywords

Anterior chamber; Endophthalmitis; Fibrin; Injections; Tissue plasminogen activator

Indexed keywords

ANTIBIOTIC AGENT; FIBRIN; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ANTERIOR EYE CHAMBER; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; CATARACT EXTRACTION; CLOSED ANGLE GLAUCOMA; CONJUNCTIVITIS; ENDOPHTHALMITIS; FEMALE; FIBRIN DEPOSITION; FIBRINOLYSIS; HUMAN; LENS IMPLANT; MALE; PAIN; SLIT LAMP;

EID: 0035722850     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.1016/S0008-4182(01)80020-X     Document Type: Article

References (12)

1. Endophthalmitis
2. Management of fibrin papillary-block glaucoma after pars plana vitrectomy with intravitreal gas injection
3. Treatment of total hyphema with relatively low-dose tissue plasminogen activator
4. Intracameral tissue plasminogen activator after glaucoma surgery. Indications, effectiveness, and complications
5. Treatment of postvitrectomy fibrin pupillary block with tissue plasminogen activator
6. Treatment of postvitrectomy fibrin formation with intraocular tissue plasminogen activator
7. Tissue plasminogen activator for postvitrectomy fibrin formation
8. Stability of recombinant tissue plasminogen activator
9. The roles of fibrinogen and fibrin in hemostasis and thrombosis
10. Retinal toxicity of human tissue plasminogen activator in vitrectomized rabbit eyes
11. Retinal toxicity of commercial intravitreal tissue plasminogen activator solution in cat eyes
12. The lowest effective dose of tissue plasminogen activator for fibrinolysis of postvitrectomy fibrin